School of Pharmacy and Pharmaceutical Sciences, Trinity College, Dublin 2, Ireland.
Bioorg Med Chem. 2011 Aug 15;19(16):4985-99. doi: 10.1016/j.bmc.2011.06.055. Epub 2011 Jun 25.
Matrix metalloproteinases are implicated in a wide range of pathophysiological processes and potent selective inhibitors for these enzymes continue to be eagerly sought. 5,5-Disubstituted barbiturates hold promise as inhibitor types being stable in vivo and relatively selective for the gelatinases (MMP-2 and MMP-9). In this paper we describe the synthesis of 5-piperazine and -homopiperazine substituted barbiturates. The activity of these compounds as gelatinase inhibitors was evaluated using supernatants from 12-O-tetradecanoylphorbol-13-acetate (PMA)-stimulated HT-1080 cells as well as using recombinant human MMPs. N-Acyl homopiperazine compounds were found to be potent inhibitors of the gelatinases (range in nM) and generally more potent than the corresponding piperazine analogues. The panel of N-acyl homopiperazines was enlarged in order to exploit differences between the gelatinases at the S2' site in order to design MMP-2- or MMP-9-selective inhibitors. Compounds in this group exhibited single digit nano-molar potency and some selectivity between the two enzymes. Representative potent compounds were effective inhibitors of cancer cell migration.
基质金属蛋白酶参与广泛的病理生理过程,因此人们一直急切地寻求这些酶的强效选择性抑制剂。5,5-二取代巴比妥酸盐作为抑制剂具有很大的应用前景,因为它们在体内稳定,对明胶酶(MMP-2 和 MMP-9)具有相对选择性。在本文中,我们描述了 5-哌嗪基和 -高哌嗪基取代的巴比妥酸盐的合成。使用 PMA 刺激的 HT-1080 细胞上清液以及重组人 MMP 来评估这些化合物作为明胶酶抑制剂的活性。发现 N-酰基高哌嗪化合物是明胶酶的强效抑制剂(纳摩尔范围内),通常比相应的哌嗪类似物更有效。为了利用 MMP-2 或 MMP-9 选择性抑制剂在 S2' 位点的明胶酶之间的差异,扩大了 N-酰基高哌嗪的组合。该组化合物具有个位数纳摩尔的效力,并在两种酶之间具有一定的选择性。代表性的有效化合物是有效的癌细胞迁移抑制剂。